(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | 123.75%1.97M | ---- | -85.39%880K | ---- | 66.23%6.02M | ---- | 141.71%3.62M | ---- | -192.77%-8.69M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | 79.04%-35K | ---- | -1.21%-167K | ---- | 47.78%-165K | ---- | 5.67%-316K | ---- | -11,066.67%-335K |
Interest expense - adjustment | ---- | -21.95%32K | ---- | 20.59%41K | ---- | -41.38%34K | ---- | 38.10%58K | ---- | 61.54%42K |
Dividend (income)- adjustment | ---- | ---- | ---- | 14.29%-6K | ---- | -40.00%-7K | ---- | 66.67%-5K | ---- | 11.76%-15K |
Impairment and provisions: | ---- | 230.25%1.66M | ---- | -209.62%-1.28M | ---- | -55.25%1.16M | ---- | -54.69%2.6M | ---- | 2.61%5.74M |
-Impairmen of inventory (reversal) | ---- | ---- | ---- | -27.58%239K | ---- | 58.65%330K | ---- | 29.19%208K | ---- | -59.75%161K |
-Impairment of trade receivables (reversal) | ---- | 198.42%1.49M | ---- | -281.65%-1.52M | ---- | -65.15%834K | ---- | 61.04%2.39M | ---- | 124.81%1.49M |
-Impairment of goodwill | ---- | --171K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Other impairments and provisions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -9.71%4.09M |
Revaluation surplus: | ---- | ---3M | ---- | ---- | ---- | 318.06%301K | ---- | 1,300.00%72K | ---- | -100.20%-6K |
-Other fair value changes | ---- | ---3M | ---- | ---- | ---- | 318.06%301K | ---- | 1,300.00%72K | ---- | -100.20%-6K |
Asset sale loss (gain): | ---- | -20.00%-6K | ---- | ---5K | ---- | ---- | ---- | --1.32M | ---- | ---- |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --563K | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | -20.00%-6K | ---- | ---5K | ---- | ---- | ---- | ---- | ---- | ---- |
-Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --754K | ---- | ---- |
Depreciation and amortization: | ---- | 5.92%4.04M | ---- | 2.52%3.82M | ---- | 5.71%3.72M | ---- | 16.62%3.52M | ---- | 50.10%3.02M |
-Depreciation | ---- | 7.11%3.99M | ---- | 2.76%3.73M | ---- | 5.80%3.63M | ---- | 17.03%3.43M | ---- | 55.69%2.93M |
-Other depreciation and amortization | ---- | -43.82%50K | ---- | -6.32%89K | ---- | 2.15%95K | ---- | 3.33%93K | ---- | -30.77%90K |
Special items | ---- | -268.48%-155K | ---- | 370.59%92K | ---- | -240.00%-34K | ---- | ---10K | ---- | ---- |
Operating profit before the change of operating capital | ---- | 33.47%4.51M | ---- | -69.42%3.38M | ---- | 1.63%11.04M | ---- | 4,570.37%10.86M | ---- | -102.10%-243K |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | 133.44%4.98M | ---- | -442.94%-14.88M | ---- | -326.90%-2.74M | ---- | -83.61%1.21M | ---- | -46.41%7.37M |
Accounts receivable (increase)decrease | ---- | -202.82%-11.37M | ---- | 193.61%11.05M | ---- | -221.74%-11.81M | ---- | -157.80%-3.67M | ---- | 37.59%6.35M |
Accounts payable increase (decrease) | ---- | -179.39%-4.38M | ---- | 252.20%5.51M | ---- | 208.07%1.57M | ---- | 105.10%508K | ---- | 35.37%-9.96M |
Special items for working capital changes | ---- | 134.22%386K | ---- | -208.57%-1.13M | ---- | -49.39%1.04M | ---- | 68.56%2.05M | ---- | -47.93%1.22M |
Cash from business operations | ---- | -249.39%-5.87M | ---- | 534.48%3.93M | ---- | -108.26%-905K | ---- | 131.66%10.96M | ---- | -71.94%4.73M |
Other taxs | ---- | 79.66%-118K | ---- | -1,015.38%-580K | ---- | ---52K | ---- | ---- | ---- | 98.45%-6K |
Special items of business | 81.39%-1.18M | ---- | -184.59%-6.34M | ---- | 6.33%7.5M | ---- | -48.35%7.05M | ---- | 217.65%13.65M | ---- |
Net cash from operations | 81.39%-1.18M | -278.76%-5.99M | -184.59%-6.34M | 450.26%3.35M | 6.33%7.5M | -108.73%-957K | -48.35%7.05M | 131.95%10.96M | 217.65%13.65M | -71.27%4.73M |
Cash flow from investment activities | ||||||||||
Interest received - investment | ---- | ---- | ---- | 28,900.00%290K | ---- | -99.68%1K | ---- | -5.67%316K | ---- | 11,066.67%335K |
Dividend received - investment | ---- | ---- | ---- | -14.29%6K | ---- | 40.00%7K | ---- | -66.67%5K | ---- | -11.76%15K |
Loan receivable (increase) decrease | ---- | ---- | ---- | ---128K | ---- | ---- | ---- | ---- | ---- | ---- |
Sale of fixed assets | ---- | 438.58%684K | ---- | --127K | ---- | ---- | ---- | ---- | ---- | ---- |
Purchase of fixed assets | ---- | 58.34%-1.92M | ---- | -241.82%-4.62M | ---- | 73.08%-1.35M | ---- | 38.77%-5.02M | ---- | -2.03%-8.2M |
Selling intangible assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --15K | ---- | ---- |
Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --13K | ---- | ---- |
Recovery of cash from investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -95.68%80K |
Cash on investment | ---- | ---- | ---- | ---1.22M | ---- | ---- | ---- | ---- | ---- | 86.48%-222K |
Other items in the investment business | 40.54%-465K | ---- | 77.35%-782K | ---- | -452.48%-3.45M | ---- | 74.33%-625K | ---- | -35.13%-2.44M | ---- |
Net cash from investment operations | 40.54%-465K | 77.64%-1.24M | 77.35%-782K | -312.88%-5.55M | -452.48%-3.45M | 71.24%-1.34M | 74.33%-625K | 41.54%-4.67M | -35.13%-2.44M | 9.45%-7.99M |
Net cash before financing | 76.91%-1.65M | -229.78%-7.23M | -276.16%-7.12M | 4.65%-2.19M | -37.07%4.04M | -136.55%-2.3M | -42.71%6.43M | 292.98%6.29M | 183.67%11.22M | -142.74%-3.26M |
Cash flow from financing activities | ||||||||||
Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.24M | ---- | ---- |
Interest paid - financing | ---- | 21.95%-32K | ---- | -20.59%-41K | ---- | 41.38%-34K | ---- | -38.10%-58K | ---- | ---42K |
Other items of the financing business | 147.70%114K | ---- | -6.22%-239K | ---- | -1.81%-225K | ---- | 11.24%-221K | ---- | -105.55%-249K | ---- |
Net cash from financing operations | 147.70%114K | 1.34%-443K | -6.22%-239K | 2.81%-449K | -1.81%-225K | -159.38%-462K | 11.24%-221K | 274.83%778K | -105.55%-249K | -109.91%-445K |
Effect of rate | -105.83%-85K | 145.22%1.66M | 139.43%1.46M | -1,486.15%-3.66M | -826.92%-3.7M | -115.32%-231K | 116.43%509K | -29.24%1.51M | -469.69%-3.1M | 166.30%2.13M |
Net Cash | 79.21%-1.53M | -190.50%-7.68M | -292.80%-7.36M | 4.34%-2.64M | -38.45%3.82M | -139.06%-2.76M | -43.43%6.21M | 290.80%7.07M | 222.92%10.97M | -149.96%-3.71M |
Begining period cash | -49.84%6.06M | -34.31%12.07M | -34.31%12.07M | -14.00%18.38M | -14.00%18.38M | 67.05%21.37M | 85.56%21.37M | -10.96%12.79M | -19.84%11.52M | 41.36%14.37M |
Cash at the end | -28.04%4.44M | -49.84%6.06M | -66.65%6.17M | -34.31%12.07M | -34.14%18.5M | -14.00%18.38M | 44.87%28.09M | 67.05%21.37M | 208.53%19.39M | -10.96%12.79M |
Cash balance analysis | ||||||||||
Cash and bank balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 85.56%21.37M | ---- | -19.84%11.52M |
Cash and cash equivalent balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 85.56%21.37M | ---- | -19.84%11.52M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data